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Abstract  
Introduction: Overweight and obesity are among the most important modifiable risk factors 
for chronic diseases and premature death. The aim of this review was to systematically assess 
and analyze the effects of yoga on weight-related outcomes. 
Methods: Medline/PubMed, Scopus, and the Cochrane Library were screened through March 
2015 for randomized controlled trials on yoga for weight-related outcomes in the general 
population or overweight/obese individuals. Risk of bias was assessed using the Cochrane 
risk of bias tool on the following domains: selection bias, performance bias, detection bias, 
attrition bias, reporting bias, and other bias. 
Results: Out of 445 records identified during literature search, 30 trials with a total of 2,173 
participants were included. No effects on weight, body mass index, body fat percentage or 
waist circumference were found. In studies with healthy adult participants an effect of yoga 
compared to usual care (SMD =-1.00; 95%CI=-1.44,-0.55; p<0.001) was found regarding 
waist/hip ratio. In studies with overweight/obese participants only, effects relative to usual 
care were found for body mass index (SMD=-0.99; 95%CI =-1.67,-0.31; p=0.004). Effects 
however were not robust against selection bias; and publication bias could not be ruled out. 
No intervention-related adverse events were reported. 
Conclusions: Despite methodological drawbacks, yoga can be preliminarily considered a safe 
and effective intervention to reduce body mass index in overweight or obese individuals. 
Keywords: Yoga; complementary therapies; body weight; overweight; obesity 
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Highlights 
- Thirty randomized controlled trials with more than 2,000 participants have 
investigated the effects of yoga on weight-related outcomes. 
- Yoga does not influence weight, body fat percentage or waist circumference.  
- Yoga can reduce waist/hip ratio in healthy adults; and body mass index in 
overweight/obese individuals. 
- The reported effects are limited by the high risk of bias in individual studies and risk 
of publication bias.
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Introduction 
Overweight and obesity are among the most important modifiable risk factors for chronic 
diseases and premature death.
1
 About 69% of the US population are overweight or obese.
2
 
Worldwide the point prevalence is 39%; with increasing rates especially in low- and middle-
income countries.
1
 Besides inadequate diet, the most important contributing factor to 
overweight and obesity is a sedentary lifestyle.
3
 Thus, regular physical activity is 
recommended in medical guidelines as the most important treatment option in non-morbid 
overweight or obesity; as well as a preventive intervention.
4-6
 Given that a considerable 
number of individuals with weight problems is not adherent to recommended exercise 
regimens,
7
 the investigation of alternative forms of exercise for weight-related outcomes 
seems warranted. 
One such alternative form of physical activity that is increasingly used for health purposes is 
yoga.
8,9
 Yoga is most often associated with physical postures (‘Asana’), breath control 
(‘Pranayama’), and meditation (‘Dhyana’) in North America and Europe;8,10 and is gaining 
increased popularity as a therapeutic method for various health isues. About 14 million adult 
Americans (6.1% of the population) reported that yoga had been recommended to them by a 
physician or therapist.
11
 Indeed, about 80% of American yoga practitioners (more than 16 
million people) reported that they had started practice explicitly to improve their health;
12-14
 
and weight control is among the most frequently stated reasons for starting to practice.
15
 
While there is evidence to suggest that yoga is effective in promoting weight loss and 
improving body composition,
16
 no systematic review and/or meta-analysis on yoga for 
weight-related outcomes is available to date. Thus, the aim of this review was to 
systematically assess and analyze the effects of yoga on weight-related outcomes in the 
general population and in overweight/obese individuals by means of a meta-analysis. 
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Methods 
This review was conducted in accordance with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines
17
 and recommendations of the Cochrane 
Collaboration.
18
  
Eligibility criteria 
Types of studies 
Randomized controlled trials (RCTs) and cluster-randomized trials were eligible. No 
language restrictions were applied. 
Types of participants 
Studies on  
a) children or adolescents or  
b) adults  
were included if participants were  
i) healthy or from the general population (i.e. not selected based on their health 
status or weight) or  
ii) overweight or obese.  
The different subgroups were compared in subgroup analyses (a vs. b; i vs. ii). 
Studies were excluded if overweight or obesity were comorbidities of diseases investigated in 
the trials, for example in studies investigating obese patients with hypertension. However, 
studies on participants with disease risk factor constellations, which are not a disease in itself, 
such as metabolic syndrome, were eligible. Studies on pregnant women and patients with 
eating disorders (anorexia nervosa, bulimia, binge eating) were excluded. 
Types of interventions 
Experimental: 
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Studies were eligible if they included at least one of the following yoga practices based on 
yoga theory:  
i) yoga postures or sequences of yoga postures 
ii) breath control, meditation, and/or  
iii) lifestyle advice.  
No restrictions were made regarding the tradition of the yoga intervention, the length, 
frequency or duration of the programs. Studies on multimodal interventions including yoga 
amongst others were excluded. Studies allowing individual co-interventions were eligible.  
Control: 
Studies comparing yoga to  
i) usual care 
ii)  exercise 
iii) or other active control interventions  
were eligible, but studies with head to head comparisons of different yoga interventions 
without non-yoga control groups were excluded. 
Types of outcome measures 
To be eligible for inclusion, studies had to assess at least one primary weight-related outcome: 
i) body weight 
ii) body mass index 
iii) body fat percentage 
iv) waist circumference 
v) waist-hip ratio. 
Secondary outcomes included safety of the intervention, assessed as number of patients with 
adverse events (AEs). 
Search methods 
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The search strategy comprised three electronic databases from their inception through March 
09, 2015: Medline/PubMed, Scopus, and the Cochrane Central Register of Controlled Trials. 
The literature search was constructed around search terms for 1. “yoga” and 2. “weight” and 
adapted for each database as necessary. The complete search strategy for PubMed/Medline is 
shown in the appendix. 
Additionally, reference lists of identified original articles or reviews; and the tables of 
contents of the International Journal of Yoga Therapy and the Journal of Yoga & Physical 
Therapy were searched manually; and trials identified as randomized controlled trials in a 
bibliometric analysis were checked for outcomes.
19
 Two reviewers independently screened 
and selected abstracts; potentially eligible articles were read in full by two reviewers. 
Disagreements were resolved through discussion with a third reviewer until consensus was 
reached. If necessary, additional information was obtained from the authors of the primary 
study. 
Data extraction and management 
Two reviewers independently extracted data on patient characteristics (e.g. age, gender, 
ethnicity), interventions (e.g. yoga type, frequency, and duration), control interventions (e.g. 
type, frequency, duration), and outcomes (e.g. outcome measures, assessment time points) 
using an a priori developed data extraction form. Discrepancies were resolved by discussion 
with a third reviewer until consensus was reached. 
Assessment of risk of bias in individual studies 
Two reviewers independently assessed risk of bias using the Cochrane risk of bias tool.
18
 This 
tool assesses risk of bias on seven domains: random sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of outcome assessment, 
incomplete outcome data, selective reporting, and other sources of bias. For each domain, risk 
of bias was assessed as low; unclear; or high risk of bias. Discrepancies were discussed with a 
third reviewer until consensus was reached. 
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Data analysis 
Assessment of overall effect size 
Separate meta-analyses were conducted for comparisons of yoga to different control 
interventions. Meta-analyses were conducted using Review Manager 5 software (Version 5.2, 
The Nordic Cochrane Centre, Copenhagen) by random effects models if at least two studies 
assessing this specific outcome were available. Standardized mean differences (SMD) with 
95% confidence intervals (CI) were calculated as the difference in means between groups 
divided by the pooled standard deviation using Hedges’s correction for small study samples.18 
Where no standard deviations were available, they were calculated from standard errors, 
confidence intervals or t-values,
18
 or attempts were made to obtain the missing data from the 
trial authors directly.  
For all outcomes a negative SMD (i.e. lower scores in the yoga group) were defined to 
indicate beneficial effects of yoga compared to the control intervention. If necessary, values 
were inverted.
18
 Cohen's categories were used to evaluate the magnitude of the overall effect 
size with SMD<0.2: negligible; SMD=0.2-0.5: small; SMD=0.5-0.8: medium; and SMD>0.8: 
large effect sizes.
20
 
Assessment of heterogeneity 
Statistical heterogeneity between studies was analyzed using the I
2
 statistics; a measure of 
how much variance between studies can be attributed to differences between studies rather 
than chance. The magnitude of heterogeneity was categorized as (1) I
2
=0–24%: low 
heterogeneity; I
2
=25–49%: moderate; I2=50–74%: substantial; and I2=75–100%: 
considerable.
18,21
 The Chi
2
 test was used to assess whether differences in results are 
compatible with chance alone. Due the low power of this test in cases where only a few 
studies or studies with low sample size are included, a P-value ≤ 0.10 was regarded to indicate 
significant heterogeneity.
20
 
Subgroup and sensitivity analyses 
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Subgroup analyses were performed for the age of participants (children/adolescents vs. adults) 
and their weight status (participants . not selected based on their weight vs. overweight/obese 
participants).  
To test the robustness of significant results, sensitivity analyses were conducted for studies 
with high versus low risk of selection bias (random sequence generation and allocation 
concealment).  
If present in the respective meta-analysis, subgroup and sensitivity analyses were also used to 
explore possible reasons for statistical heterogeneity. 
Risk of bias across studies 
If at least ten studies were included in a meta-analysis, publication bias was assessed by visual 
inspection of funnel plots generated using Review Manager software.
18,22
 Roughly 
symmetrical funnel plots were regarded to indicate low risk of publication bias; and 
asymmetrical funnel plots were regarded to indicate high risk of publication bias. 
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Results 
Literature search 
The literature search retrieved 435 non-duplicate records of which 158 full-texts were 
assessed for eligibility, and 31 of them were eligible,
23-53
 while 127 of those full-texts were 
excluded (table 1) 
54-180 
Thirty-one full-text articles reporting on 30 RCTs involving a total of 2,173 participants were 
included in the qualitative analysis; and 27 articles on 26 RCTs were meta-analyzed (Figure 
1). All but one article (published in Chinese)
35
 were published in English. 
Study characteristics 
Characteristics of the samples, interventions, outcome assessments, and results are shown in 
Appendix Table 1. 
Study and participant characteristics 
Of the 30 studies that were included, 15 originated from India,
23,30,31,33,36-40,43,45-47,51,53
 8 from 
the USA,
24,27,29,32,44,48-50
 3 from Korea,
34,42,52
 2 from Taiwan,
25,26
, and one each from Japan
41
 
and China.
35
 Ten of the trials explicitly investigated overweight or obese 
individuals;
27,30,32,34,42,43,45,51-53
 and three trials were conducted on children/adolescents.
23,42,46
 
The sample size ranged from 17 to 204 with a median of 60. Participant’s mean age ranged 
from 10.4 to 75.4 years with a median of 50.0 years. A median of 48.3% of participants was 
female. 
Intervention characteristics 
Two studies each used Silver yoga
25,26
 and Hatha Yoga,
40,52
 one each used Restorative 
Yoga,
32
 Yogasana,
41
 Bikram,
48
 Vinyasa Yoga,
50
 and yogic lifestyle intervention;
36
 and 21 did 
not report the yoga style used (Appendix Table 1). Twenty-six studies reported using yoga 
postures while one used only breathing exercises; and the majority of trials also utilized 
breathing, meditation or relaxation exercises. The duration of yoga programs ranged from 2-
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52 weeks with a median of 12 weeks; participants practiced yoga on 1-7 days per week 
(median: 3.5) with session of 10-90 (median: 60) minutes length. Intervention adherence was 
reported by only nine studies;
24,25,29,31,32,38,53,181,50
 participants in those studies attended a mean 
of 63.0%-95.8% (median: 78.2%) of the prescribed yoga sessions. Regarding control 
interventions, nineteen studies compared yoga to usual care or no specific treatment, eight 
studies compared yoga to exercise, three studies compared yoga to lifestyle 
modification;
36,38,47
 and one trial compared yoga combined with diet to diet alone.
43
 One trial 
compared yoga to herbal medicines 
37
 and could therefore not be included in the meta-
analysis. In addition to a yoga group and a non-yoga exercise control group, one trial included 
a combination of yoga and exercise as a third study arm.
35
 This third group was not included 
in the meta-analysis. Another trial compared two different yoga interventions with each other 
and with an untreated control group.
25
 In meta-analysis, the two yoga interventions could be 
combined into one group. In most exercise studies yoga and exercise interventions were 
matched for program length, frequency and duration of the sessions.  
Outcome measures 
All studies assessed outcomes immediately after the end of the intervention. Body weight was 
assessed in 22 studies, body mass index in 17, body fat percentage in 9, waist circumference 
in 15 and waist hip ratio in 6 studies. Safety was reported in five trials only. 
Risk of bias in individual studies 
Risk of bias in individual studies is shown in Table 2. Eleven studies had reported adequate 
random sequence generation, but only seven reported allocation concealment; none of the 
trials reported blinding of patients and personnel; but six studies reported adequate blinding of 
outcome assessement; fourteen trials had low risk of attrition bias, and eighteen were free of 
suspected selective reporting. 
Analysis of overall effect 
Primary outcomes 
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Meta-analyses revealed no effects on weight (figure 2), BMI, body fat percentage or waist 
circumference for yoga compared to usual care, exercise or lifestyle modification. For waist 
hip ratio a significant effect was found for yoga compared to usual care (SMD =-1.00; 95% CI 
=-1.44 to -0.55; p<0.0001), see Table 3. One trial compared yoga to an herbal medicine 
compound but did not include statistical tests for group differences.
30
 
 
Subgroup analysis (see Appendix Tables 2-5) 
No effects were found for trials including children/adolescents only. Effects were the same in 
trials for adults only or for participants not selected for weight status only compared to the 
complete sample.  
For studies on overweight or obese participants significant effects were found for body mass 
index only (SMD =-0.99; 95% CI =-1.67 to -0.31; p=0.004) for yoga compared to usual care. 
Sensitivity analysis 
Due to the paucity of eligible trials, no sensitivity analyses could be conducted for studies 
with low risk of selection bias. 
Safety 
Only seven studies reported safety-related data, however they stated that no adverse events 
were reported,
27,41
 no adverse events during the intervention occurred,
45,49
, no clinically 
significant adverse events were reported or observed,
30
 that no special concerns were found
25
 
or that no participant dropped out because of side effects.
52
 
Risk of bias across studies 
Funnel plots were asymmetrical for weight, body mass index, and waist circumference; 
indicating high risk of publication bias (see Appendix Figure 1). 
 
Discussion 
Summary of evidence 
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In this systematic review of 30 randomized controlled trials, only little evidence for effects of 
yoga on weight-related outcomes has been found. Significant changes in body mass index 
were identified only in studies with overweight/obese participants practicing yoga compared 
to usual care, while significant effects for waist hip ratio were found for yoga compared to 
usual care in adults who were not selected based on their weight only. Effects however were 
not robust against potential methodological bias and publication bias could not be ruled out. 
Furthermore safety was insufficiently reported.  
Agreements with prior systematic reviews 
Only one prior review explicitly investigated the effects of yoga on weight and related 
parameters. Rioux and Ritenbaugh
16
 conducted a narrative review, and included 17 trials that 
used yoga as an intervention for weight loss; among them uncontrolled, controlled and 
randomized controlled trials. Their risk assessment was based on a self-developed instrument. 
The authors concluded that therapeutic yoga was frequently effective in promotion weight 
loss or improving body composition in included trials. They also found that increased 
frequency, longer duration, dietary components, residential components, a multi-component 
yoga and home practice increased the effectiveness. 
In comparison our current review found only very limited evidence of yoga’s efficacy for 
weight control in overweight/obese patients; however effects were not robust against bias. 
Subgroup analysis or meta-regression based on intensity, duration and yoga components 
could not be conducted due to heterogeneity of trials with very little overlap. The present 
review had also used the Cochrane risk of bias tool and found only a few trials with low risk 
of selection bias in general. 
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Another review on the effects of yoga on cardiovascular risk factors found effects of yoga on 
waist circumference and waist/hip ratio in high-risk groups but did not include other weight-
related outcomes.
123
 Other reviews reported comparable effects.
182,183
 
Strengths and weaknesses 
To the best of our knowledge, this is the first systematic review and/or meta-analysis 
available on yoga for weight management. Strengths of this review include the 
comprehensive literature search and the inclusion of yoga trials on the general population as 
well as overweight/obese participants. The primary limitation of this review is the paucity of 
eligible studies especially for overweight/obese participants, rendering further subgroup 
analyses impossible. Another major limitation is the insufficient reporting and/or low 
methodological quality of the included studies, limiting the interpretability of the results. 
Intervention adherence was reported in less than one third of the included studies; thus the 
influence of adherence on study outcomes could not be evaluated.  The inclusion of studies on 
metabolic syndrome can be regarded as a limitation because metabolic syndrome – although 
not defined as a disease – might nevertheless be associated with pronounced symptoms. 
How the intervention might work 
Whilst yoga is often considered a form of exercise, beginner-level yoga sessions  are not 
ordinarily considered sufficient for improving cardiovascular fitness.
184
 More intensive forms 
of yoga however can contribute to higher energy expenditure;
184-186
 and can thus contribute to 
weight loss and maintenance.
187
 Moreover, yoga can ameliorate back and joint pain,
188-191
 and 
increase levels of other, non-yoga physical activity.
192
 Beyond exercise, yoga can also 
encompass yogic dietary advice; as well as relaxation, meditation, breath control and positive 
thinking. Thus, yoga has been shown to effectively decrease chronic depression
193
 and 
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stress;
194
 which might in turn reduce emotional overeating and resulting overweight.
195
 This 
way, yoga interventions target both, physical and emotional maintaining factors of obesity. 
Implications for further research 
Given that the main drawback of this review was the insufficient reporting of trial 
methodology, authors of future research should improve the reporting of yoga trials and 
follow commonly accepted reporting guidelines (e.g. CONSORT).
196
 Further trials should 
ensure rigorous methodology such as a-priori sample size calculations to prevent the trial 
from being underpowered. They should further ensure adequate randomization, allocation 
concealment, intention-to-treat analysis, and blinding of at least outcome assessors.
196
 
Only seven trials in this review explicitly investigated overweight/obese samples, and two of 
them could not be included in the meta-analysis due to their unique control groups. The 
remaining trials – when combined – only included 60 patients in the meta-analytic 
comparison of yoga and usual care. More trials on yoga for overweight or obese people 
therefore are warranted. Since overweight and obesity might also be associated with eating 
disorders, trials on for example binge eating are urgently needed, as such participants may 
require special consideration. 
Future trials must also improve reporting of safety. Even though a systematic review of 
randomized controlled trials found no evidence for serious yoga-associated adverse events or 
an accumulation of adverse events compared to usual care or exercise,
197
 evidence was 
limited because only one third of the trials actually reported safety and most of them 
insufficiently. Yoga has also been occasionally associated with serious adverse events.
198
 
Especially overweight and obese patients may be required to present a certain physical 
fitness; and certain poses might be associated with an increased risk of injuries. This should 
be an additional focus of further trials. 
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Implications for clinical practice 
Based on the results of this meta-analysis, no recommendation can be made for or against 
yoga to influence weight-related outcomes in children and adolescents. Despite the 
methodological drawbacks of the included trials, yoga can however be preliminarily 
considered a safe and effective intervention to reduce body mass index in overweight or obese 
but otherwise healthy adults. It has been shown that while women and younger individuals are 
less adherent to physical activity interventions targeting overweight and obesity,
199
 those 
individuals are however more likely to practice yoga.
12,200
 Thus, yoga can be specifically 
considered as an alternative to other forms of physical activity for overweight/obese 
individuals who are not adherent to recommended physical activity regimens. 
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Figure captions 
Figure 1: Flowchart of the results of the literature search. 
Figure 2: Forest plot and effect sizes for yoga compared to usual care, exercise and lifestyle 
modification for the outcome weight. 
Appendix Figure 1: Funnel plot for yoga compared to usual care, exercise and lifestyle 
modification for the outcome weight. 
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Table 1: Excluded studies 
Excluded study (Reference) Reason for exclusion 
54
 Commentary 
55-62
 Conference abstract 
63-67
 Trial protocol 
68-70
 No clinical trial  
71-92
 Not controlled  
93-117
 Not randomized  
118-120
 Secondary analysis 
121-129
 Review  
130
 Not published in a peer-reviewed journal  
131-160
 Involved diseased participants 
161-170
 No weight-related outcome  
171-180
 No yoga 
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Table 2: Risk of Bias assessment 
Reference Random 
sequence 
generation 
(selection bias) 
Allocation 
concealment  
(selection bias) 
Blinding of 
participants and 
personnel 
(performance bias) 
Blinding of 
outcome assessment 
(detection bias) 
Incomplete outcome 
data (attrition bias) 
Selective 
reporting 
(reporting bias) 
Other bias 
Bera, 1993 unclear unclear unclear unclear unclear unclear low 
Blumenthal, 1989 unclear unclear unclear unclear low high low 
Chen, 2008 low high unclear unclear low high low 
Chen, 2010 unclear high unclear unclear low high high 
Cohen, 2008 unclear high high unclear low low high 
Elavsky, 2007 low unclear unclear low low high low 
Harbans, 2011 unclear unclear unclear unclear high low high 
Hedge, 2013 low unclear high high low low low 
Kim, 2013 low low unclear low low low low 
Kanaya, 2014 unclear low unclear unclear low low low 
Kanoja, 2013 unclear unclear unclear unclear unclear low low 
Khatri, 2007 unclear unclear unclear unclear unclear high high 
Lee, 2012 unclear unclear unclear unclear low low low 
Lu, 2007 unclear unclear unclear unclear unclear low low 
Mahajan, 1999 unclear unclear unclear unclear unclear low low 
Manchanda, 2013 unclear unclear high high high low unclear 
Manjunath, 2012 low low unclear unclear low High high 
McDermott, 2014 low low high low low low low 
Mooventhan, 2014 low low unclear unclear low low low 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
21 
Ray, 2001 unclear unclear unclear unclear high low low 
Sakuma, 2012 low low unclear unclear high High high 
Shukla Ravi, 2014 unclear unclear unclear unclear unclear unclear high 
Seo, 2012 unclear unclear unclear unclear high low low 
Stachenfeld, 1998 unclear unclear unclear unclear unclear low high 
Telles, 2013 low unclear unclear low low low high 
Telles, 2014 low unclear unclear unclear high unclear high 
Thiyagarayan, 2015 low low high high high low high 
Tracy, 2013 unclear unclear unclear unclear high unclear high 
Van Puymbroeck, 2007 unclear unclear high low high low high 
Yang, 2011 unclear unclear unclear low low low low 
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Table 3: Results of the meta-analysis over all studies for body mass index, body fat 
percentage, waist circumference and waist hip ratio. Legend: BF: body fat; BMI: body mass 
index; EX: exercise; LSM: lifestyle modification; UC: usual care; WC: waist circumference; 
WHR: waist hip ratio. 
Outcome Comp. Study Yoga 
Mean 
Yoga 
SD 
N Control 
Mean 
Control 
SD 
N Weight SMD [95% CI] 
BMI UC Chen et al., 2008 24.24 4.96 110 24.48 4.03 66 12.6% -0.05 [-0.36, 0.25] 
  Cohen et al., 2008 -0.1 0.9 12 0.8 2.7 12 9.1% -0.43 [-1.24, 0.38] 
  Hedge et al., 2013 26.8 3.5 14 26.3 4.4 15 9.7% 0.12 [-0.61, 0.85] 
  Lee et al., 2012 24.24 1.43 8 26.01 1.61 8 7.4% -1.10 [-2.17, -0.03] 
  Manchanda et al., 2013 31.29 3.99 34 33.65 4.9 43 11.7% -0.52 [-0.97, -0.06] 
  Mooventhan et al., 
2014 
22.37 4.279 40 20.82 3.336 39 11.7% 0.40 [-0.05, 0.85] 
  Sakuma et al., 2012 20.7 2.7 67 20.8 2.5 31 11.9% -0.04 [-0.46, 0.39] 
  Seo et al., 2012 27.56 1.5 10 29.57 2.97 10 8.4% -0.82 [-1.74, 0.10] 
  Shukla et al., 2014 -1.97 0.7 30 -0.76 0.42 30 10.4% -2.07 [-2.70, -1.43] 
  van Puymbroeck et 
al.,2007 
32.07 12.9 6 28.83 8.31 7 7.2% 0.28 [-0.82, 1.38] 
  Total   331   261 100.0% -0.40 [-0.83, 0.04] 
  Overall effect Z = 1.79 (P = 0.07) 
  Heterogeneity Chi² = 49.55, df = 9 (P < 0.00001); I² = 82% 
 EX Lu et al., 2007 23.08 1.77 21 23.4 1.31 21 21.1% -0.20 [-0.81, 0.40] 
  Stachenfeld et al., 
1998 
27.0 2.7 9 26.8 1.7 7 7.9% 0.08 [-0.91, 1.07] 
  Telles et al., 2013 16.34 1.88 49 16.6 2.78 49 49.4% -0.11 [-0.50, 0.29] 
  Telles et al., 2014 36.61 6.54 22 33.8 5.76 22 21.6% 0.45 [-0.15, 1.05] 
  Total   101   99 100.0% 0.01 [-0.27, 0.29] 
  Overall effect Z = 0.05 (P = 0.96) 
  Heterogeneity Chi² = 2.88, df = 3 (P = 0.41); I² = 0% 
BF (%) UC Bera et al., 1993 3.71 6.3 20 10.05 8.4 20 17.7% -0.84 [-1.49, -0.19] 
  Chen et al., 2010 28.7 9.27 31 29.0 9.03 24 18.7% -0.03 [-0.57, 0.50] 
  Lee et al., 2012 33.83 4.31 8 37.45 2.7 8 14.1% -0.95 [-2.00, 0.10] 
  Seo et al., 2012 35.66 6.05 10 36.15 6.55 10 15.7% -0.07 [-0.95, 0.80] 
  Shukla et al., 2014 -3.00 1.06 30 -1.03 1.37 30 18.3% -1.59 [-2.18, -1.00] 
  Tracy et al., 2013  27.3 6.3 10 21.0 8.4 11 15.5% 0.81 [-0.09, 1.71] 
  Total   109   103 100.0% -0.47 [-1.15, 0.22] 
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  Overall effect Z = 1.33 (P = 0.18) 
  Heterogeneity Chi² = 26.97, df = 5 (P < 0.0001); I² = 81% 
 EX Lu et al., 2007 29.0 3.05 21 29.03 2.49 21 61.1% -0.01 [-0.62, 0.59] 
  Ray et al., 2001 9.5 2.0 17 9.5 2.7 11 38.9% 0.00 [-0.76, 0.76] 
  Total   38   32 100.0% -0.01 [-0.48, 0.47] 
  Overall effect Z = 0.03 (P = 0.98) 
  Heterogeneity Chi² = 0.00, df = 1 (P = 0.98); I² = 0% 
WC UC Bera et al., 1993 60.29 5.23 20 63.2 7.83 20 14.9% -0.43 [-1.06, 0.20] 
  Cohen et al., 2008 -2.7 3.0 12 -2.7 5.0 12 13.5% 0.00 [-0.80, 0.80] 
  Hedge et al., 2013 89.4 9.1 14 90.0 13.7 15 14.1% -0.05 [-0.78, 0.68] 
  Kim et al., 2013 90.0 5.2 17 90.52 9.1 20 14.8% -0.07 [-0.71, 0.58] 
  Lee et al., 2012 85.13 1.36 8 86.44 1.95 8 11.7% -0.74 [-1.76, 0.29] 
  Manchanda et al., 2013 95.12 5.12 34 98.0 7.3 43 16.2%  -0.44 [-0.90, 0.01] 
  Shukla et al., 2014 -3.53 1.5 30 -0.96 0.49 30 14.7% -2.27 [-2.93, -1.61] 
  Total   135    148 100.0% -0.57 [-1.17, 0.02] 
  Overall effect Z = 1.90 (P = 0.06) 
  Heterogeneity Chi² = 32.54, df = 6 (P < 0.0001); I² = 82% 
 EX Kanaya, 2014 -1.7 4.25 88 -0.8 5.04 83 43.1% -0.19 [-0.49, 0.11] 
  Lu, 2007 82.05 0.09 21 81.02 3.72 21 22.8% 0.38 [-0.23, 1.00] 
  Stachenfeld, 1998 90.7 4.5 9 94.7 4.6 7 10.4% -0.83 [-1.87, 0.21] 
  Telles, 2014 109.83 13.28 22 108.18 14.41 22 23.7% 0.12 [-0.47, 0.71] 
  Total   140   133 100.0% -0.05 [-0.42, 0.32] 
  Overall effect Z = 0.29 (P = 0.77) 
  Heterogeneity Chi² = 5.18, df = 3 (P = 0.16); I² = 42% 
 LSM McDermott, 2014 -4.2 4.71 20 0.7 4.71 18 42.4% -1.02 [-1.70, -0.34] 
  Thiyagarayan, 2015 82.96 6.26 51 85.06 8.0 49 57.6% -0.29 [-0.69, 0.10] 
  Total   71   67 100.0% -0.60 [-1.30, 0.11] 
  Overall effect Z = 1.67 (P = 0.10) 
  Heterogeneity Chi² = 3.28, df = 1 (P = 0.07); I² = 70% 
WHR UC Hedge et al., 2013 0.88 0.04 15 0.93 0.08 14 34.1% -0.78 [-1.54, -0.02] 
  Shukla et al., 2014 -0.02 0.01 30 -0.01 0.01 30 65.9% -1.11 [-1.66, -0.57] 
  Total   45   44 100.0% -1.00 [-1.44, -0.55] 
  Overall effect Z = 4.41 (P < 0.0001) 
  Heterogeneity Chi² = 0.49, df = 1 (P = 0.48); I² = 0% 
 EX Lu, 2007 0.69 0.03 21 0.79 0.02 21 32.6% -3.85 [-4.90, -2.79] 
  Stachenfeld, 1998 0.92 0.03 9 0.93 0.04 7 32.9% -0.27 [-1.27, 0.72] 
  Telles, 2014 0.91 0.05 22 0.93 0.08 22 34.5% -0.29 [-0.89, 0.30] 
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  Total   52   50 100.0% -1.45 [-3.56, 0.66]  
  Overall effect Z = 1.34 (P = 0.18) 
  Heterogeneity Chi² = 35.44, df = 2 (P < 0.00001); I² = 94% 
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Appendix: Complete search strategy for PubMed/Medline. 
(Yoga[MeSH Terms] OR Yoga*[Title/Abstract] OR Yogic[Title/Abstract] OR Asana*[Title/Abstract] 
OR Pranayama[Title/Abstract]) AND (Body Weights and Measures[MeSH Terms] OR Body 
Weight[MeSH Terms] OR Body Composition[MeSH Terms] OR Weight*[Title/Abstract] OR Body 
Mass Index[Title/Abstract] OR BMI[Title/Abstract] OR Body Fat[Title/Abstract] OR fat 
mass[Title/Abstract] OR Body Composition[Title/Abstract] OR Adiposity[Title/Abstract] OR 
Obes*[Title/Abstract] OR Overweight[Title/Abstract] OR Waist Circumference[Title/Abstract] OR 
Waist-Hip Ratio*[Title/Abstract]) AND (Randomized Controlled Trial [Publication Type] OR 
controlled clinical trial[Publication Type] OR randomized[Title/Abstract] OR placebo[Title/Abstract] 
OR randomly[Title/Abstract] OR trial[Title/Abstract] OR groups[Title/Abstract]) NOT 
(Animals[MeSH Terms] NOT humans[MeSH Terms])
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Appendix Table 1: Characteristics of the included studies. Legend: NA: not assessed, NR: not reported, f: female; m:male 
Reference Origin 
 
Overweight 
as inclusion 
criterion 
Sample 
 
Sample size; mean age; gender; ethnicity 
 
Intervention 
 
Intervention; program length; 
frequency; duration 
 
Components of yoga 
intervention 
Control group 
 
Intervention; program 
length; frequency; duration 
Outcome assessment time 
point 
 
Outcome measures: 
 
1. Weight 
2. Body Mass Index 
3. Body fat percentage 
4. Fat mass (absolute) 
5. Waist circumference 
6. Waist hip ratio 
7. Safety 
Bera, 1993 India no  Sample size: n=40 (n=20 each) 
Mean age: 12-15 years 
Gender: 100%m 
Ethnicity: NR 
 
 
Yoga 
1 year 
3x/week 
45 min. each 
 
Asana 
Pranayama 
Meditation 
No treatment 1 year 1. Weight 
2. NA 
3. Body fat percentage 
4. Fat mass 
5. NA 
6. NA 
7. NA 
Blumenthal, 
1989 
USA no 
 
Sample size: n=101 (Yoga n=34; exercise 
n=33, no treatment n=34) 
Mean age: Yoga 67.8±5.9 years; exercise 
66.5±4.3 years; no treatment 66.8±4.3 
years 
Gender: 50f, 51m 
Ethnicity: 96% White 
 
 
Yoga 
16 weeks 
2x/week 
60 min. each 
 
NR 
1) Aerobic exercise 
16 weeks  
3x/week 
60 min. each 
 
2) No treatment 
16 weeks 1. Weight 
2. NA 
3. NA 
4. NA 
5. NA 
6. NA 
7. NA 
Chen, 2008 Taiwan no Sample size: n=204 (Yoga n=64, short 
yoga n=59, no treatment n=66) 
Mean age: 69.0±6.3 years 
Gender: 72.7%f 
Ethnicity: NR 
 
 
Silver Yoga 
24 weeks 
3x/week 
70 min. each 
 
Asana 
Meditation 
Relaxation 
1) Short yoga intervention 
(group combined with 
interventional group for 
meta-analysis) 
24 weeks 
3x/week 
55 min. each 
 
Asana 
Relaxation 
 
24 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. NA 
6. NA 
7. NA 
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2) No treatment 
Chen, 2010 Taiwan no Sample size: n=69 (Yoga n=38, control 
n=31) 
Mean age: 75.4±6.7 years 
Gender: 52.7%f 
Ethnicity: NR 
 
 
Silver Yoga 
24 weeks 
3x/week 
70 min. each 
 
Asana 
Meditation 
Relaxation 
No treatment 24 weeks 1. NA 
2. NA 
3. Body fat percentage 
4. NA 
5. NA 
6. NA 
7. Special concerns 
Cohen, 2008 USA yes 
 
 
Sample size: n=26 (Yoga n=14; control 
n=12) 
Mean age: Yoga 52±9 years; control 52±8 
years 
Gender: 100%m 
Ethnicity: 45% Caucasians 
 
Yoga 
 
10 weeks 
3 hour introductory course 
2x/week (weeks 1-5) 
1x/week (weeks 6-10) 
90 min each 
 
Asanas 
Pranayama 
Relaxation 
No intervention 10 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. Waist circumference 
6. NA 
7. Adverse events 
Elavsky, 
2007 
(multiple 
publications) 
 
USA no Sample size: n=164 (Yoga n=62; exercise 
n=63; usual care n= 39) 
Mean age: Yoga 50.0±3.7 years; exercise 
50.5±3.4; usual care 48.6±3.5 
Gender: 100%f 
Ethnicity: 82.6% Caucasians; 12.6% 
Blacks 
 
Yoga  
16 weeks  
2x/week  
90 min each 
 
Asanas  
Mediation 
1) Exercise  
16 weeks  
2x/week  
90 min each                  
 
2) Usual care 
16 weeks 1. NA 
2. NA 
3. Body fat percentage (NR) 
4. NA 
5. NA 
6. NA 
7. NA 
Harbans, 
2011 
India yes Sample size: n=63 (Yoga n=34; control 
n=29) 
Age range: 20-70 years 
Gender: NR 
Ethnicity: NR 
 
 
Yoga 
8 weeks 
2x/day 
45 min. each 
 
 
 
 
Herbal medicine 
Lashunadi compound 
8 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. Waist circumference 
6. Waist hip ratio 
7. Significant adverse events 
Hedge, 2013 India no Sample size: n=29 (Yoga n=14, control 
n=15) 
Yoga 
12 weeks 
No intervention 12 weeks 1. NA 
2. Body Mass Index 
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Mean age: Yoga 46.5±13.0 years; control 
44.7±9.6 years 
Gender: 14f, 15m 
Ethnicity: NR 
 
 
5x/week 
75-90 min each 
 
Asanas 
Pranayama 
Relaxation 
3. NA 
4. NA 
5. Waist circumference 
6. Waist hip ratio 
7. NA 
Kanaya, 2014 USA yes Sample size: n=180 (Yoga n=91, control 
n=89) 
Mean age: Yoga 55±7 years; control 54±7 
years 
Gender: 124f, 47m 
Ethnicity: Caucasians n=112 
 
 
Restorative Yoga 
48 weeks 
2x/week (weeks 1-12) 
1x/week (weeks 13-24) 
1x/month (weeks 24 weeks-
48) 
 
Asanas 
Stretching 
48 weeks 
2x/week (weeks 1-12) 
1x/week (weeks 13-24) 
1x/month (weeks 24 weeks-
48) 
 
 
12 months 1. Weight 
2. Body Mass Index 
3. Body fat percentage 
4. NA 
5. Waist circumference 
6. NA 
7. NA 
 
Kanojia, 
2013 
India no Sample size: n=50 (n=25 each) 
Mean age: Yoga 18.6±1.1 years; control 
18.1±0.8 years 
Gender: 100%f 
Ethnicity: NR 
 
 
Yoga 
3 months 
6x/week 
35-40 min. each 
 
Asanas 
Pranayama 
Meditation 
Relaxation 
No intervention 3 months 1. Weight 
2. NA 
3. NA 
4. NA 
5. NA 
6. NA 
7. NA 
Khatri, 2007 India no Sample size: n=101 (Yoga n=55; control 
n=46) 
Mean age: Yoga 54.1±8.8 years; control 
54.0±11.2 years 
Gender: NR 
Ethnicity: NR 
Yoga 
3 months 
 
Usual care 3 months 1. NA 
2. Body Mass Index 
3. NA 
4. NA 
5. Waist circumference 
6. NA 
7. NA 
Kim, 2013 South 
Korea 
yes Sample size: n=41 (Yoga n=20; control 
n=21) 
Mean age: Yoga 48.2±7.2 years; control 
50.3±8.3 years 
Gender: 100%f 
Ethnicity: NR 
 
 
Hatha Yoga 
12 weeks 
3x/week 
60 min each 
 
Asanas 
Pranayama 
Relaxation 
Usual care 12 weeks 1. NA 
2. NA 
3. NA 
4. NA 
5. Waist circumference 
6. NA 
7. Drop outs due to side effects 
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Lee, 2012 Korea yes Sample size: n=16 (Yoga n=8, control 
n=8) 
Mean age: Yoga 54.8±2.8 years; control 
54.3±2.9 years 
Gender: 100%f 
Ethnicity: NR 
 
 
Yoga  
16 weeks 
3x/week 
60 min. each 
 
Asanas 
Pranayama 
Relaxation 
No intervention 16 weeks 1. Weight 
2. Body Mass Index 
3. Body fat percentage 
4. NA 
5. Waist circumference 
6. NA 
7. NA 
Lu, 2007 China no Sample size: n=63 (n=21 each) 
Age: NR 
Gender: 100%f 
Ethnicity: NR 
 
 
Yoga  
 
Asanas 
Relaxation 
1) Aerobic exercise 
 
2) Aerobic + yoga (group 
not included in meta-
analysis) 
10 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA  
5. Waist circumference 
6. Waist hip ratio 
7. NA 
Mahajan, 
1999 
India no Sample size: n=53 (n=30 Yoga, n=23 
control) 
Age range 56-90 years 
Gender: 100%m 
Ethnicity: NR 
 
 
Yogic Lifestyle Intervention 
4 day initial residential yoga 
camp 
+ 14 weeks home practice (60 
min. daily) 
 
Asanas 
Pranayama 
Meditation 
Relaxation 
+ Vegetarian diet 
Lifestyle advice 
 
Diet control and moderate 
exercise 
14 weeks 1. Weight 
2. NA 
3. NA 
4. NA 
5. NA 
6. NA 
7. NA 
Manchanda, 
2013 
India yes Sample size: n=100 (n=50 each) 
Mean age: Yoga 62.4±12.5 years; control 
56.7±12.8 years 
Gender: 49f, 51f 
Ethnicity: NR 
 
 
Yoga 
1 week yoga instruction 
+ 12 months home practice (60 
min. daily) 
 
Asanas 
Pranayama 
Meditation 
Relaxation 
Lifestyle 
Usual care  
 
 
12 months 1. Weight 
2. BMI 
3. NA 
4. NA 
5. Waist circumference 
6. NA 
7. NA 
Manjunath, 
2012 
 
India no Sample size: n=69 (n=23 each) 
Mean age: Yoga 70.1±8.3 years; control 1) 
72.1±9.0 years; control 2) 72.3±7.4 years 
Yoga  
24 weeks 
6x/week 
1) Ayurvedic herbal 
preparation 
24 weeks 
6 months 1. NA 
2. Body Mass Index (NR) 
3. NA 
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Gender: NR 
Ethnicity: NR 
 
 
60 min each 
 
Asanas 
Pranayama 
Meditation 
Relaxation 
2x/day 
 
2) No intervention 
4. NA 
5. NA  
6. NA 
7. NA 
McDermott, 
2014 
India no Sample size: n=41 (Yoga n=21, control 
n=20) 
Mean age: Yoga 47.0±9.7 years, control 
47.2±9.1 years 
Gender: 16m, 25f 
Ethnicity: NR 
 
 
Yoga  
8 weeks  
3-6x/week 
75 min. each  
 
Asanas 
Pranayama 
Relaxation 
Meditation 
Lifestyle advice and home-
based walking  
8 weeks  
3-6x/week 
30 min. each  
 
8 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. Waist circumference 
6. NA 
7. NA 
Mooventhan, 
2014 
India no Sample size: n=82 (n=41 each) 
Mean age: Yoga 19.8±1.7 years, control 
19.7±2.0 years 
Gender: 64f, 18m 
Ethnicity: NR 
 
 
Yoga 
2 weeks 
6 days/week  
10 min./day  
 
Pranayama 
No intervention 2 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. NA 
6. NA 
7. NR 
Ray, 2001 India no Sample size: n=40 (n=20 each) 
Mean age: Yoga 21.9±1.5 years; control 
22.7±2.0 years 
Gender: 100%m 
Ethnicity: NR 
 
 
Hatha Yoga  
6 months 
6x/week 
60 min. each 
 
Asana 
Pranayama 
Relaxation 
Meditation 
Exercise 
6 months 
6x/week 
60 min. each 
 
6 months 1. Weight 
2. NA 
3. Body fat percentage 
4. Fat mass (absolute) 
5. NA 
6. NA 
7. NA 
Sakuma, 
2012 
Japan 
 
no Sample size: n=123 (Yoga n=83, control 
n=40) 
Mean age: Yoga 32.6±11.5 years; control 
35.8±13.0 years 
Gender: 100%f 
Ethnicity: NR 
 
 
Yogasanas  
2 weeks 
7x/week  
15 min each 
 
Asanas 
Pranayama 
No intervention 4 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. NA 
6. NA 
7. Adverse events 
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Seo, 2012 
 
Korea yes Sample size: n=20 (n=10 each) 
Mean age: Yoga 14.7±0.5 years; control: 
14.6±1.0 years 
Gender: 100%m 
Ethnicity: NR 
 
 
Yoga  
 
8 weeks 
3x/week 
60 min. each 
 
Asanas  
Relaxation 
No treatment 8 weeks 1. Weight 
2. Body Mass Index 
3. Body fat percentage 
4. Fat mass (absolute) 
5. NA 
6. NA 
7. NA 
Shukla, 2014 India yes Sample size: n=60 (n=30each) 
Age: 25-55 years 
Gender: 27m, 33f 
Ethnicity: NR 
 
Yoga 
 
90 days Kapalabhati 50x/day; 
Paschimottanasana 20x/day 
 
Asana 
Pranayama 
 
+Diet 
Diet 
 
90 days 
1600 Kcal/day 
 
90 days 1. Weight 
2. Body Mass Index 
3. Body fat percentage 
4. Fat mass (absolute, body fat, 
visceral fat) 
5. Waist circumference 
6. Waist hip ratio 
7. NA 
Stachenfeld, 
1998 
DiPietro, 
1998 
USA no Sample size: n=17 (Yoga n=8, control 
n=9) 
Mean age: Yoga 71±2 years; control 73±3 
years 
Gender: 100%f 
Ethnicity:  NR 
Yoga 
 
12 weeks 
3-4x/week 
60 min each 
 
Asanas 
Aerobic exercise 
 
12 weeks 
3-4x/week 
40-50 min each 
 
Treadmill or trampoline 
walking 
12 weeks 1. Weight 
2. Body Mass Index 
3. NA 
4. NA 
5. NA 
6. NA 
7. NA 
Telles, 2013  
 
India no Sample size: n=98 (Yoga n=49, control 
n=49) 
Mean age: Yoga 10.4±1.2 years; control 
10.5±1.3 years 
Gender: 38f, 60m 
Ethnicity: NR 
 
 
Yoga 
 
3 months  
5x/week 
45 min each 
 
Asanas 
Pranayama 
Relaxation 
Physical exercise  
 
3 months  
5x/week  
45 min each 
3 months 1. Weight (NR) 
2. Body Mass Index 
3. NA  
4. Fat mass (NR) 
5. Waist circumference 
6. Waist hip ratio 
7. NA 
Telles, 2014 India yes Sample size: n=68 (Yoga n=34, control 
n=34) 
Age: Yoga 36.0±10.3 years, control 
36.8±12.1 years 
Gender: 33m, 35f 
Yoga 
 
15 days 
2x/day 
45 min. each 
Walking  
 
15 days 
2x/day 
45 min. each 
15 days 1. NA 
2. Body Mass Index 
3. NA 
4. Fat mass 
5. Waist circumference 
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Ethnicity: NR 
 
 
Asanas, Pranayama, 
Relaxation 
6. Waist hip ratio 
7. Adverse events 
Thiyagarayan
, 2015 
India no Sample size: n=192 (n=96 each) 
Mean age: Yoga 44.1±9.4 years; control 
42.5±9.0 years 
Gender: 62m, 38f 
Ethnicity: NR 
 
 
Yoga 
 
12 weeks 
3x/week 
45 min. each 
 
Asanas 
Pranayama 
Relaxation 
 
+ LSM (see control) 
Lifestyle Modification 
 
12 weeks 
 
Diet 
Physical activity 
Maintaining/Reducing 
weight 
12 weeks 1. Weight 
2. Body Mass Index 
3. NA  
4. NA 
5. Waist circumference 
6. NA 
7. NA 
 
 
Tracy, 2013 USA no Sample size: n=21 (Yoga n=21, control 
n=11) 
Mean age: 29.0±6.1 years; control 
25.1±5.0 years 
Gender: 11f, 10m 
Ethnicity: NR 
 
 
Bikram Yoga 
 
8 weeks 
3x/week 
90 min each. 
 
Asanas 
 
 
No intervention 8 weeks 1. Weight (NR) 
2. NA 
3. Body fat percentage 
4. Fat mass (absolute) (NR) 
5. NA 
6. NA 
7. NA 
Van 
Puymbroeck, 
2007 
USA no Sample size: n=17 (Yoga n=8, control 
n=9) 
Mean age: Yoga 55.17±15.0 years; control 
62.7±10.8 years 
Gender: 4m, 9f 
Ethnicity: Caucasian (n=12/13) 
 
 
Yoga 
 
8 weeks 
2x/week 
75 min each 
 
Asanas 
Pranayama 
Usual care 8 weeks 1. NA  
2. Body Mass Index 
3. NA 
4. NA 
5. NA 
6. NA 
7. Adverse events during yoga 
sessions 
Yang, 2011 USA no Sample size: n=25 (Yoga n=13, control 
n=12) 
Mean age: 51.7±4.9 years 
Gender: 21f, 2m 
Ethnicity: Caucasians n=19 
 
Vinyasa Yoga  
 
12 weeks 
2x/week 
60 min each 
 
General health education 
(written information) 
12 weeks 1. Weight 
2. NA 
3. NA 
4. NA 
5. NA 
6. NA 
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 Asanas, Pranayama, 
Relaxation 
7. NA 
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Appendix Table 2: Results of the meta-analysis for studies with overweight/obese participants 
only.  
Outcome Comp Study Yoga 
Mean 
Yoga  
SD 
N Control 
Mean 
Control 
SD 
N Weight SMD [95% CI] 
Weight UC Cohen et al., 2008  -0.1 2.7 12 2.2 9.0 12 19.8% -0.33 [-1.14, 0.47] 
  Lee et al., 2012 58.06 4.31 8 62.88 4.5 8 17.8% -1.03 [-2.10, 0.03] 
  Manchanda et al., 
2013 
86.91 12.53 34 89.14 13.55 43 22.3% -0.17 [-0.62, 0.28] 
  Seo et al., 2012 74.49 7.06 10 78.13 10.44 10 19.2% -0.39 [-1.28, 0.50] 
  Shukla et al., 2014 -5.2 1.48 30 -2.16 1.02 30 20.9% -2.36 [-3.03, -1.69] 
  Total   94   103 100.0% -0.86 [-1.76, 0.05] 
  Overall effect Z = 1.86 (P = 0.06)  
  Heterogeneity Chi² = 30.61, df = 4 (P < 0.00001); I² = 87% 
BMI UC Cohen et al., 2008 -0.1 0.9 12 0.8 2.7 12 19.6% -0.43 [-1.24, 0.38] 
  Lee et al., 2012 24.24 1.43 8 26.01 1.61 8 16.2% -1.10 [-2.17, -0.03] 
  Manchanda et al., 
2013 
31.29 3.99 34 33.65 4.9 43 24.2% -0.52 [-0.97, -0.06] 
  Seo et al., 2012 27.56 1.5 10 29.57 2.97 10 18.1% -0.82 [-1.74, 0.10] 
  Shukla et al., 2014 -1.97 0.7 30 -0.76 0.42 30 22.0% -2.07 [-2.70, -1.43] 
  Total   94   103 100.0% -0.99 [-1.67, -0.31] 
  Overall effect Z = 2.86 (P = 0.004) 
  Heterogeneity Chi² = 17.10, df = 4 (P = 0.002); I² = 77% 
BF (%) UC Lee et al., 2012 33.83 4.31 8 37.45 2.7 8 29.1% -0.95 [-2.00, 0.10] 
  Seo et al., 2012 35.66 6.05 10 36.15 6.55 10 32.5% -0.07 [-0.95, 0.80] 
  Shukla et al., 2014 -3.00 1.055 30 -1.03 1.37 30 38.4% -1.59 [-2.18, -1.00] 
  Total   48   48 100.0% -0.91 [-1.86, 0.04] 
  Overall effect Z = 1.87 (P = 0.06) 
  Heterogeneity Chi² = 8.02, df = 2 (P = 0.02); I² = 75% 
WC UC Cohen et al., 2008 -2.7 3.0 12 -2.7 5.0 12 19.4% 0.00 [-0.80, 0.80] 
  Kim et al., 2013 90.0 5.2 17 90.52 9.1 20 20.7% -0.07 [-0.71, 0.58] 
  Lee et al., 2012 85.13 1.36 8 86.44 1.95 8 17.4% -0.74 [-1.76, 0.29] 
  Manchanda et al., 
2013 
95.12 5.12 34 98.0 7.3 43 22.1% -0.44 [-0.90, 0.01] 
  Shukla et al., 2014 -3.53 1.5 30 -0.96 0.49 30 20.6% -2.27 [-2.93, -1.61] 
  Total   101   113 100.0% -0.71 [-1.53, 0.12] 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
35 
  Overall effect Z = 1.68 (P = 0.09) 
  Heterogeneity Chi² = 29.77, df = 4 (P < 0.00001); I² = 87% 
 EX Kanaya, 2014 -1.7 4.25 88 -0.8 5.04 83 79.5% -0.19 [-0.49, 0.11] 
  Telles, 2014 109.83 13.28 22 108.18 14.41 22 20.5% 0.12 [-0.47, 0.71] 
  Total   110   105 100.0% -0.13 [-0.40, 0.14] 
  Overall effect Test for overall effect: Z = 0.95 (P = 0.34) 
  Heterogeneity Chi² = 0.84, df = 1 (P = 0.36); I² = 0% 
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Appendix Table 3: Results of the meta-analysis for studies with healthy participants/general 
population only.  
Outcome Comp. Study Yoga 
Mean 
Yoga 
SD 
N Control 
Mean 
Control 
SD 
N Weight SMD [95% CI] 
Weight UC Bera et al., 1993  44.81 9.39 20 40.28 8.65 20 11.0% 0.49 [-0.14, 1.12] 
  Blumenthal et al., 1989 0.6 2.7 34 0.3 1.7 34 15.1% 0.13 [-0.34, 0.61] 
  Chen et al., 2008 58.97 9.39 110 61.77 8.65 66 21.1% -0.31 [-0.61, 0.00] 
  Kanojia et al., 2013 50.72 8.93 25 49.15 6.85 25 12.8% 0.19 [-0.36, 0.75] 
  Mooventhan et al., 
2014 
57.52 12.18 40 51.97 11.08 39 16.0% 0.47 [0.02, 0.92] 
  Sakuma et al., 2012 52.1 8.0 67 52.2 7.5 31 16.7% -0.01 [-0.44, 0.41] 
  Yang et al., 2011 79.24 13.52 12 85.91 13.34 10 7.3% -0.48 [-1.33, 0.38] 
  Total   308   225 100.0% 0.07 [-0.19, 0.34] 
  Overall effect Z = 0.54 (P = 0.59) 
  Heterogeneity Chi² = 12.30, df = 6 (P = 0.06); I² = 51% 
 EX Blumenthal et al., 1989 0.6 2.7 34 0.5 1.7 33 34.3% 0.04 [-0.44, 0.53] 
  Lu et al., 2007 62.66 6.01 21 61.49 5.41 21 28.7% 0.20 [-0.41, 0.81] 
  Ray et al., 2001 62.2 3.5 17 64.1 3.9 11 22.6% -0.50 [-1.28, 0.27] 
  Stachenfeld et al., 
1998 
64.0 4.0 9 69.0 4.0 7 14.5% -1.18 [-2.28, -0.09] 
  Total   81   71 100.0% -0.21 [-0.71, 0.28] 
  Overall effect Z = 0.85 (P = 0.40) 
  Heterogeneity Chi² = 6.08, df = 3 (P = 0.11); I² = 51% 
 LSM Mahajan et al., 1999 70.48 10.48 30 74.29 12.04 23 27.4% -0.34 [-0.88, 0.21] 
  McDermott et al., 2014 -0.2 1.26 20 0.6 1.26 18 19.2% -0.62 [-1.28, 0.03] 
  Thiyagarayan et al., 
2015 
67.12 9.5 51 68.34 11.52 49 53.3% -0.11 [-0.51, 0.28] 
  Total   101   90 100.0% -0.27 [-0.56, 0.01] 
  Overall effect Z = 1.87 (P = 0.06) 
  Heterogeneity Chi² = 1.78, df = 2 (P = 0.41); I² = 0% 
BMI UC Chen et al., 2008 24.24 4.96 110 24.48 4.03 66 44.7% -0.05 [-0.36, 0.25] 
  Hedge et al., 2013 26.8 3.5 14 26.3 4.4 15 9.7% 0.12 [-0.61, 0.85] 
  Mooventhan et al., 
2014 
22.37 4.28 40 20.82 3.34 39 15.3% 0.40 [-0.05, 0.85] 
  Sakuma et al., 2012 20.7 2.7 67 20.8 2.5 31 16.8% -0.04 [-0.46, 0.39] 
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  vanPuymbroeck et 
al.,2007 
32.07 12.9 6 28.83 8.31 7 2.5% 0.28 [-0.82, 1.38] 
  Total   237    158 100.0% 0.07 [-0.13, 0.28] 
  Overall effect Z = 0.69 (P = 0.49) 
  Heterogeneity Chi² = 3.12, df = 4 (P = 0.54); I² = 0% 
 EX Lu et al., 2007 23.08 1.77 21 23.4 1.31 21 26.9% -0.20 [-0.81, 0.40] 
  Stachenfeld et al., 
1998 
27.0 2.7 9 26.8 1.7 7 10.1% 0.08 [-0.91, 1.07] 
  Telles et al., 2013 16.34 1.88 49 16.6 2.78 49 63.0% -0.11 [-0.50, 0.29] 
  Total   79   77 100.0% -0.11 [-0.43, 0.20] 
  Overall effect Z = 0.71 (P = 0.48) 
  Heterogeneity Chi² = 0.23, df = 2 (P = 0.89); I² = 0% 
BF (%) UC Bera et al., 1993 3.71 6.3 20 10.05 8.4 20 34.3% -0.84 [-1.49, -0.19] 
  Chen et al., 2010 28.7 9.27 31 29.0 9.03 24 36.9% -0.03 [-0.57, 0.50] 
  Tracy et al., 2013 27.3 6.3 10 21.0 8.4 11 28.8% 0.81 [-0.09, 1.71] 
  Total   61   55 100.0% -0.07 [-0.89, 0.76] 
  Overall effect Z = 0.16 (P = 0.87) 
  Heterogeneity Chi² = 8.86, df = 2 (P = 0.01); I² = 77% 
 EX Lu et al., 2007 29.0 3.05 21 29.03 2.49 21 61.1% -0.01 [-0.62, 0.59] 
  Ray et al., 2001 9.5 2.0 17 9.5 2.7 11 38.9% 0.00 [-0.76, 0.76] 
  Total   38   32 100.0% -0.01 [-0.48, 0.47] 
  Overall effect Z = 0.03 (P = 0.98) 
  Heterogeneity Chi² = 0.00, df = 1 (P = 0.98); I² = 0% 
WC UC Bera et al., 1993 60.29 5.23 20 63.2 7.83 20 57.4% -0.43 [-1.06, 0.20] 
  Hedge et al., 2013 89.4 9.1 14 90.0 13.7 15 42.6% -0.05 [-0.78, 0.68] 
  Total   34   35 100.0% -0.27 [-0.74, 0.21] 
  Overall effect Z = 1.10 (P = 0.27) 
  Heterogeneity Chi² = 0.60, df = 1 (P = 0.44); I² = 0% 
 EX Lu et al., 2007 82.05 0.09 21 81.02 3.72 21 56.3% 0.38 [-0.23, 1.00] 
  Stachenfeld et al., 
1998 
90.7 4.5 9 94.7 4.6 7 43.7% -0.83 [-1.87, 0.21] 
  Total   30   28 100.0% -0.15 [-1.33, 1.03] 
  Overall effect Z = 0.25 (P = 0.81) 
  Heterogeneity Chi² = 3.90, df = 1 (P = 0.05); I² = 74% 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
38 
 LSM McDermott et al., 2014 -4.2 4.71 20 0.7 4.71 18 42.4% -1.02 [-1.70, -0.34] 
  Thiyagarayan et al., 
2015 
82.96 6.26 51 85.06 8.0 49  57.6% -0.29 [-0.69, 0.10] 
  Total   71   67 100.0% -0.60 [-1.30, 0.11] 
  Overall effect Z = 1.67 (P = 0.10) 
  Heterogeneity Chi² = 3.28, df = 1 (P = 0.07); I² = 70% 
WHR UC Hedge et al., 2013 0.88 0.04 15 0.93 0.08 14 34.1% -0.78 [-1.54, -0.02] 
  Shukla et al., 2014 -0.02 0.01 30 -0.01 0.01 30 65.9% -1.11 [-1.66, -0.57] 
  Total   45   44 100.0% -1.00 [-1.44, -0.55] 
  Overall effect Z = 4.41 (P < 0.0001) 
  Heterogeneity Chi² = 0.49, df = 1 (P = 0.48); I² = 0% 
 EX Lu et al., 2007 0.69 0.03 21 0.79 0.02 21 32.6% -3.85 [-4.90, -2.79] 
  Stachenfeld et al., 
1998 
0.92 0.03 9 0.93 0.04 7 
32.9% 
-0.27 [-1.27, 0.72] 
  Telles et al., 2014 0.91 0.05 22 0.93 0.08 22 34.5% -0.29 [-0.89, 0.30] 
  Total   52   50 100.0% -1.45 [-3.56, 0.66] 
  Overall effect Z = 1.34 (P = 0.18) 
  Heterogeneity Chi² = 35.44, df = 2 (P < 0.00001); I² = 94% 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
39 
Appendix Table 4: Results of the meta-analysis for studies with children/adolescent participants 
only.  
Outcome Comp Study Yoga 
Mean 
Yoga  
SD 
N Control 
Mean 
Control 
SD 
N Weight SMD [95% CI] 
Weight UC Bera, 1993 44.81 9.39 20 40.28 8.65 20 56.5% 0.49 [-0.14, 1.12] 
  Seo, 2012 74.49 7.06 10 78.13 10.44 10 43.5% -0.39 [-1.28, 0.50] 
  Total   30   30 100.0% 0.11 [-0.75, 0.97] 
  Overall effect Z = 0.25 (P = 0.81) 
  Heterogeneity Chi² = 2.53, df = 1 (P = 0.11); I² = 60% 
BF (%) UC Bera, 1993 3.71 6.3 20 10.05 8.4 20 57.8% -0.84 [-1.49, -0.19] 
  Seo, 2012 35.66 6.05 10 36.15 6.55 10 42.2% -0.07 [-0.95, 0.80] 
  Total   30   30 100.0% -0.52 [-1.25, 0.22] 
  Overall effect Z = 1.37 (P = 0.17) 
  Heterogeneity Chi² = 1.88, df = 1 (P = 0.17); I² = 47%  
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
40 
Appendix Table 5: Results of the meta-analysis for studies with adult participants only.  
Outcome Comp. Study Yoga 
Mean 
Yoga 
SD 
N Control 
Mean 
Control 
SD 
N Weight SMD [95% CI] 
Weight UC Blumenthal et al., 1989 0.6 2.7 34 0.3 1.7 34 10.9% 0.13 [-0.34, 0.61] 
  Chen et al., 2008 58.97 9.39 110 61.77 8.65 66 11.9% -0.31 [-0.61, 0.00] 
  Cohen et al., 2008 -0.1 2.7 12 2.2 9.0 12 8.6% -0.33 [-1.14, 0.47] 
  Kanojia et al., 2013 50.72 8.93 25 49.15 6.85 25 10.4% 0.19 [-0.36, 0.75] 
  Lee et al., 2012 58.06 4.31 8 62.88 4.5 8 7.0% -1.03 [-2.10, 0.03] 
  Manchanda et al., 2013 86.91 12.53 34 89.14 13.55 43 11.0% -0.17 [-0.62, 0.28] 
  Mooventhan et al., 
2014 
57.52 12.18 40 51.97 11.08 39 11.1% 0.47 [0.02, 0.92] 
  Sakuma et al., 2012 52.1 8.0 67 52.2 7.5 31 11.2% -0.01 [-0.44, 0.41] 
  Shukla et al., 2014 -5.2 1.48 30 -2.16 1.02 30 9.6% -2.36 [-3.03, -1.69] 
  Yang et al., 2011 79.24 13.52 12 85.91 13.34 10 8.3% -0.48 [-1.33, 0.38] 
  Total   372   298 100.0% -0.34 [-0.76, 0.08] 
  Overall effect Z = 1.57 (P = 0.12) 
  Heterogeneity Chi² = 56.67, df = 9 (P < 0.00001); I² = 84% 
 EX Blumenthal et al., 1989 0.6 2.7 34 0.5 1.7 33 24.4% 0.04 [-0.44, 0.53] 
  Kanaya et al., 2014 -1.3 2.83 88 -0.7 3.21 83 37.6% -0.20 [-0.50, 0.10] 
  Lu et al., 2007 62.66 6.01 21 61.49 5.41 21 18.2% 0.20 [-0.41, 0.81] 
  Ray et al., 2001 62.2 3.5 17 64.1 3.9 11 12.7% -0.50 [-1.28, 0.27] 
  Stachenfeld et al., 
1998 
64.0 4.0 9 69.0 4.0 7 7.1% -1.18 [-2.28, -0.09] 
  Total   169   154 100.0% -0.18 [-0.49, 0.14] 
  Overall effect Z = 1.11 (P = 0.27) 
  Heterogeneity Chi² = 6.21, df = 4 (P = 0.18); I² = 36% 
 LSM Mahajan et al., 1999 70.48 10.48 30 74.29 12.04 23 27.4% -0.34 [-0.88, 0.21] 
  McDermott et al., 2014 -0.2 1.26 20 0.6 1.26 18 19.2% -0.62 [-1.28, 0.03] 
  Thiyagarayan et al., 
2015 
67.12 9.5 51 68.34 11.52 49 53.3% -0.11 [-0.51, 0.28] 
  Total   101   90 100.0% -0.27 [-0.56, 0.01] 
  Overall effect Z = 1.87 (P = 0.06) 
  Heterogeneity Chi² = 1.78, df = 2 (P = 0.41); I² = 0% 
BMI UC Chen et al., 2008 24.24 4.96 110 24.48 4.03 66 13.7% -0.05 [-0.36, 0.25] 
  Cohen et al., 2008 -0.1 0.9 12 0.8 2.7 12 9.4% -0.43 [-1.24, 0.38] 
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  Hedge et al., 2013 24.24 4.96 110 24.48 4.03 66 13.7% -0.05 [-0.36, 0.25] 
  Lee et al., 2012 24.24 1.43 8 26.01 1.61 8 7.4% -1.10 [-2.17, -0.03] 
  Manchanda et al., 2013 31.29 3.99 34 33.65 4.9 43 12.5% -0.52 [-0.97, -0.06] 
  Mooventhan et al., 
2014 
22.37 4.28 40 20.82 3.34 39 12.6% 0.40 [-0.05, 0.85] 
  Sakuma et al., 2012 20.7 2.7 67 20.8 2.5 31 12.7% -0.04 [-0.46, 0.39] 
  Shukla et al., 2014 -1.97 0.7 30 -0.76 0.42 30 10.9% -2.07 [-2.70, -1.43] 
  vanPuymbroeck et 
al.,2007 
32.07 12.9 6 28.83 8.31 7 7.2% 0.28 [-0.82, 1.38] 
  Total   417   302 100.0% -0.36 [-0.77, 0.05] 
  Overall effect Z = 1.71 (P = 0.09) 
  Heterogeneity Chi² = 48.23, df = 8 (P < 0.00001); I² = 83% 
 EX Lu et al., 2007 23.08 1.77 21 23.4 1.31 21 41.1% -0.20 [-0.81, 0.40] 
  Stachenfeld et al., 
1998 
27.0 2.7 9 26.8 1.7 7 16.9% 0.08 [-0.91, 1.07] 
  Telles et al., 2014 36.61 6.54 22 33.8 5.76 22 42.0% 0.45 [-0.15, 1.05] 
  Total   52   50 100.0% 0.12 [-0.30, 0.54] 
  Overall effect Z = 0.56 (P = 0.58) 
  Heterogeneity Chi² = 2.24, df = 2 (P = 0.33); I² = 11% 
BF (%) UC Chen et al., 2010 28.7 9.27 31 29.0 9.03 24 27.0% -0.03 [-0.57, 0.50] 
  Lee et al., 2012 33.83 4.31 8 37.45 2.7 8 22.5% -0.95 [-2.00, 0.10] 
  Shukla et al., 2014 -3.0 1.06 30 -1.03 1.37 30 26.6% -1.59 [-2.18, -1.00] 
  Tracy et al., 2013 27.3 6.3 10 21.0 8.4 11 23.9% 0.81 [-0.09, 1.71] 
  Total   79   73 100.0% -0.45 [-1.50, 0.59] 
  Overall effect Z = 0.85 (P = 0.40) 
  Heterogeneity Chi² = 25.09, df = 3 (P < 0.0001); I² = 88% 
 EX Lu et al., 2007 29.0 3.05 21 29.03 2.49 21 61.1% -0.01 [-0.62, 0.59] 
  Ray et al., 2001 9.5 2.0 17 9.5 2.7 11 38.9% 0.00 [-0.76, 0.76] 
  Total   38   32 100.0% -0.01 [-0.48, 0.47] 
  Overall effect Z = 0.03 (P = 0.98) 
  Heterogeneity Chi² = 0.00, df = 1 (P = 0.98); I² = 0% 
WC UC Cohen et al., 2008 -2.7 3.0 12 -2.7 5.0 12 16.1% 0.00 [-0.80, 0.80] 
  Hedge et al., 2013 89.4 9.1 14 90.0 13.7 15 16.6% -0.05 [-0.78, 0.68] 
  Kim et al., 2013 90.0 5.2 17 90.52 9.1 20 17.3% -0.07 [-0.71, 0.58] 
  Lee et al., 2012 85.13 1.36 8 86.44 1.95 8 14.2% -0.74 [-1.76, 0.29] 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
42 
  Manchanda et al., 2013 95.12 5.12 34 98.0 7.3 43 18.6% -0.44 [-0.90, 0.01] 
  Shukla et al., 2014 -3.53 1.5 30 -0.96 0.49 30 17.2% -2.27 [-2.93, -1.61] 
  Total   115    128 100.0% -0.60 [-1.31, 0.11] 
  Overall effect Z = 1.65 (P = 0.10)  
  Heterogeneity Chi² = 32.30, df = 5 (P < 0.00001); I² = 85% 
 EX Kanaya, 2014 -1.7 4.25 88 -0.8 5.04 83 43.1% -0.19 [-0.49, 0.11] 
  Lu, 2007 82.05 0.09 21 81.02 3.72 21 22.8% 0.38 [-0.23, 1.00] 
  Stachenfeld, 1998 90.7 4.5 9 94.7 4.6 7 10.4% -0.83 [-1.87, 0.21] 
  Telles, 2014 109.83 13.28 22 108.18 14.41 22 23.7% 0.12 [-0.47, 0.71] 
  Total   140   133 100.0% -0.05 [-0.42, 0.32] 
  Overall effect Z = 0.29 (P = 0.77) 
  Heterogeneity Chi² = 5.18, df = 3 (P = 0.16); I² = 42% 
 LSM McDermott, 2014 -4.2 4.71 20 0.7 4.71 18 42.4% -1.02 [-1.70, -0.34] 
  Thiyagarayan, 2015 82.96 6.26 51 85.06 8.0 49 57.6% -0.29 [-0.69, 0.10] 
  Total   71   67 100.0% -0.60 [-1.30, 0.11] 
  Overall effect Z = 1.67 (P = 0.10) 
  Heterogeneity Chi² = 3.28, df = 1 (P = 0.07); I² = 70% 
WHR UC Hedge et al., 2013 0.88 0.04 15 0.93 0.08 14 34.1% -0.78 [-1.54, -0.02] 
  Shukla et al., 2014 -0.02 0.01 30 -0.01 0.01 30 65.9% -1.11 [-1.66, -0.57] 
  Total   45   44 100.0% -1.00 [-1.44, -0.55] 
  Overall effect Z = 4.41 (P < 0.0001) 
  Heterogeneity Chi² = 0.49, df = 1 (P = 0.48); I² = 0% 
 EX Lu, 2007 0.69 0.03 21 0.79 0.02 21 32.6% -3.85 [-4.90, -2.79] 
  Stachenfeld, 1998 0.92 0.03 9 0.93 0.04 7 32.9% -0.27 [-1.27, 0.72] 
  Telles, 2014 0.91 0.05 22 0.93 0.08  22 34.5% -0.29 [-0.89, 0.30] 
  Total   52   50 100.0% -1.45 [-3.56, 0.66] 
  Overall effect Z = 1.34 (P=0.18) 
  Heterogeneity Chi² = 35.44, df = 2 (P < 0.00001); I² = 94% 
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Appendix Figure 1 
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